Critical Insights From HealthEquity Analyst Ratings: What You Need To Know
Portfolio Pulse from Benzinga Insights
HealthEquity (NASDAQ:HQY) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased by 3.44% to $103.91. HealthEquity has shown strong revenue growth and net margins but faces challenges with ROE and ROA.
August 30, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HealthEquity has received a mix of bullish and somewhat bullish ratings from analysts, with a positive shift in the average price target. The company shows strong revenue growth and net margins but faces challenges with ROE and ROA.
The majority of analysts have a somewhat bullish outlook on HealthEquity, with a positive shift in the average price target indicating potential short-term price appreciation. The company's strong revenue growth and net margins support this positive outlook, although challenges with ROE and ROA may temper expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100